Rare diseases
Investigational molecules
Locations
Back to France646 clinical trials in Rouen, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
FranceRemibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial
FranceDurvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer
FranceTreatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia
FranceFranceEvaluating the use of capecitabine, oxaliplatin, fluorouracil, folinic acid, and irinotecan to personalize chemotherapy for patients with stage III colorectal cancer
FrancePhase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis
FranceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
FranceA study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.
FranceA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
FranceA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancers, including head and neck squamous cell carcinoma, bladder cancer, and breast cancer. Studies are evaluating novel therapeutic combinations and targeted approaches.
Multiple studies are investigating new drug combinations and personalized treatment approaches.
Research initiatives examining treatments for Alzheimer's disease, frontotemporal dementia, and multiple sclerosis. Studies focus on understanding disease mechanisms and testing novel therapeutic approaches.
Innovative approaches using advanced imaging and biomarker analysis are being explored.
Studies investigating treatments for heart failure prevention and pulmonary hypertension. Research includes evaluation of new therapeutic agents and combination treatments.
Focus on developing safer and more effective cardiovascular treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
